Found: 7
Select item for more details and to access through your institution.
Exposure equivalence between IV (0.8 mg/kg) and oral (1 mg/kg) busulfan in adult patients.
- Published in:
- European Journal of Clinical Pharmacology, 2009, v. 65, n. 9, p. 903, doi. 10.1007/s00228-009-0652-5
- By:
- Publication type:
- Article
I.V. busulfan in pediatrics: a novel dosing to improve safety/efficacy for hematopoietic progenitor cell transplantation recipients.
- Published in:
- Bone Marrow Transplantation, 2004, v. 33, n. 10, p. 979, doi. 10.1038/sj.bmt.1704446
- By:
- Publication type:
- Article
Prospective validation of a novel IV busulfan fixed dosing for paediatric patients to improve therapeutic AUC targeting without drug monitoring.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Prospective validation of a novel IV busulfan fixed dosing for paediatric patients to improve therapeutic AUC targeting without drug monitoring.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 1, p. 113, doi. 10.1007/s00280-007-0455-2
- By:
- Publication type:
- Article
Evaluation of oral versus intravenous dose of vinorelbine to achieve equivalent blood exposures in patients with solid tumours.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 3, p. 407, doi. 10.1007/s00280-007-0510-z
- By:
- Publication type:
- Article
Intravenous busulfan in adults prior to haematopoietic stem cell transplantation: a population pharmacokinetic study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 57, n. 2, p. 191, doi. 10.1007/s00280-005-0029-0
- By:
- Publication type:
- Article
Phase I/II and pharmacokinetic study of intravenous vinflunine in combination with cisplatin for the treatment of chemonaive patients with advanced non-small-cell lung cancer.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article